Sterol metabolism in the nematodeCaenorhabditis elegans
Citations Over TimeTop 10% of 1984 papers
Abstract
The metabolism of various dietary sterols and the effects of an azasteroid on sitosterol metabolism in the free-living nematodeCaenorhabditis elegans was investigated. The major unesterified sterols ofC. elegans in media supplemented with sitosterol, cholesterol or desmosterol included 7-dehydrocholesterol (66.5%, 40.5%, 31.2%, respectively), cholesterol (6.7%, 52.3%, 26.9%), lathosterol (4.4%, 3.6%, 1.7%) and 4α-methylcholest-8(14)-en-3β-ol (4.2%, 2.1%, 3.8%). Esterified sterols, representing less than 20% of the total sterols, were somewhat similar except for a significantly higher relative content of 4α-methylcholest-8(14)-en-3β-ol (23.3%, 23.4%, 10.6%). ThusC. elegans not only removes the substituent at C24 of dietary sitosterol but possesses the unusual ability to produce significant quantities of 4α-methylsterols. WhenC. elegans was propagated in medium supplemented with sitosterol plus 5 μg/ml of 25-azacoprostane hydrochloride, the azasteroid strongly interfered with reproduction and motility ofC. elegans and strongly inhibited the Δ24-sterol reductase enzyme system; excluding sitosterol, the major free sterols of azacoprostane-treatedC. elegans were cholesta-5, 7, 24-trien-3β-ol (47.9%), desmosterol (9.4%), fucosterol (2.1%) and cholesta-7,24-dien-3β-ol (2.0%). These 4 sterols are likely intermediates in the metabolism of sitosterol inC. elegans.
Related Papers
- → Applicability of non-cholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men(2009)26 cited
- → Liver transplantation modifies serum cholestanol, cholesterol precursor and plant sterol levels(1992)10 cited
- → Twenty-one year tracking of serum non-cholesterol sterols. The Cardiovascular Risk in Young Finns study(2009)9 cited
- → Abstract: 535 CHOLESTEROL ABSORPTION AND SYNTHESIS MARKERS IN INDIVIDUALS WITH AND WITHOUT A CHD EVENT DURING PRAVASTATIN THERAPY: INSIGHTS FROM THE PROSPER TRIAL(2009)
- → P231 IDENTIFICATION OF COMPOUND HETEROZYGOUS DEFICIENCY WITH A NOVEL LARGE DELETION AND Y61X OF THE LIPOPROTEIN LIPASE GENE IN JAPANESE SUBJECT(2010)